You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Case study: The LiveRLife Campaign – Jason Grebely<br />
LiverLife is a Healthy Liver Campaign designed to increase liver testing and treatment and help<br />
educate people about their liver. This study is run at participating opioid substitution treatment<br />
clinics in NSW. View Jason Grebely’s slides<br />
Key learnings from 4 clinics as follows:<br />
Engaging participants<br />
People were keen to understand what was wanted from them so emphasis placed on getting<br />
a liver scan for free: have a scan, get your card.<br />
Support from people with lived experience crucial: coffee machine, healthy food, exchange<br />
of real stories from real people all worked together to provide a positive social environment.<br />
Nurses with strong people skills were key to success in linking participants to care.<br />
CAN WE SAY 3 KEY POINTS ABOUT HCV ASSAY? VENOUS BLOOD VS FINGERPRICK? I can see<br />
sensitivity and specificity readings but what conclusions do you draw from these results?<br />
Can we explain in language for non-scientific audiences? E.g. community orgs?<br />
Results<br />
<br />
<br />
<br />
<br />
HCV RNA 13% undetectable, 23% detectable (WHAT DOES THIS MEAN TO LAY AUDIENCE? Is<br />
it accurate to say 36% had chronic HCV?)<br />
1/3 of participants had been in prison in the last 12 months<br />
Average age 43 and 68% male<br />
A high proportion - 60% - attended clinical follow up.<br />
Future directions<br />
Additional 250 participants have been recruited from homelessness settings, drug and<br />
alcohol clinics and NSPs (including POC HCV RNA testing) in Australia<br />
Planned project to evaluate LiveRLife in Bangkok, Thailand in collaboration with HIV-NAT<br />
Simplified LiveRLife intervention planned to increase testing, linkage to care and DAA<br />
therapy for ETHOS-II study (to begin in March 2017)
Change language